Are you Dr. Kanapuru?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Fairfax, VA 22031Phone+1 571-472-4724Fax+1 571-472-0241
Summary
- Dr. Bindu Kanapuru, MD is a hematologist in Fairfax, Virginia. She is currently licensed to practice medicine in Virginia and Maryland. She is affiliated with Inova Fairfax Medical Campus and Virginia Hospital Center.
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 2008 - 2011
MedStar Health/Harbor HospitalResidency, Internal Medicine, 2004 - 2007
Madras Medical CollegeClass of 1996
Certifications & Licensure
VA State Medical License 2011 - 2026
MD State Medical License 2010 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Autopsy of a Drug Withdrawal - The Case of Melphalan Flufenamide.Bindu Kanapuru, Theresa Carioti, Nicole Gormley, Richard Pazdur
The New England Journal of Medicine. 2024-12-12 - Modernizing multiple myeloma clinical trial eligibility to improve equity and inclusivity by hematological parameters.Lauren Merz, Monique Hartley-Brown, Maureen Achebe, Craig Cole, Bindu Kanapuru
Seminars in Hematology. 2024-10-25 - Most Common Symptomatic Adverse Reactions of Cancer Treatments From US Drug Labels (2015-2021) to Inform Selection of Patient-Reported Outcomes.Erica G Horodniceanu, Tejaswi Datla, Meena N Murugappan, Bindu Kanapuru, Laleh Amiri-Kordestani
Value in Health. 2024-10-09
Press Mentions
Criteria for Selecting Who Can Enroll in Multiple Myeloma Clinical Trials May Exclude Patients from Minority GroupsApril 5th, 2023
State of the Science for Multiple Myeloma: Change in the Right DirectionFebruary 14th, 2020- How We Should Run Clinical Trials in Myeloma? A Meeting Between Myeloma Experts, Industry and FDAMarch 13th, 2024
